Disc Medicine
IRON· Manufacturing· Fiscal year ends in December
John Quisel, J.D., Ph.D. is the CEO of Disc Medicine and was paid $10.0M in FY2025 (Dec), up 10%.
Executives5
See all- 1John Quisel, J.D., Ph.D.President and Chief Executive OfficerFY2025
- 2Jean FranchiChief Financial OfficerFY2025
- 3Pamela Stephenson, M.P.H.Chief Commercial OfficerFY2025
- 4William Savage, M.D., Ph.D.Chief Medical OfficerFY2025
- 5Jonathan Yu, M.B.A.Chief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allDisc Medicine paid its 5 named executives $25.3M in total in FY2025 (Dec). CEO John Quisel, J.D., Ph.D. was paid $10.0M of that.
| Name | |||
|---|---|---|---|
| John Quisel, J.D., Ph.D.President and Chief Executive Officer | |||
| Jean FranchiChief Financial Officer | Not disclosed | ||
| Pamela Stephenson, M.P.H.Chief Commercial Officer | Not disclosed | ||
| William Savage, M.D., Ph.D.Chief Medical Officer | |||
| Jonathan Yu, M.B.A.Chief Operating Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers18
See allThe FY2025 (Dec) proxy of Disc Medicine names 18 peer companies for pay. Among Disc Medicine and these peers, CEO pay was 4th highest of 6 and total shareholder return was 4th highest of 6.
4th highest of 6in Disc Medicine and its pay peers, FY2025 (Dec) by CEO pay:
4th highest of 6in Disc Medicine and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 24, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | May 1, 2024 | FY2023 |
| Annual report | 10-K | Mar 21, 2024 | FY2023 |
